Compugen Files Registration Statement With the SEC.Business Editors & High Tech Writers TEL AVIV Tel Aviv (tĕl əvēv`), city (1994 pop. 355,200), W central Israel, on the Mediterranean Sea. Oficially named Tel Aviv–Jaffa, it is Israel's commercial, financial, communications, and cultural center and the core of its largest , Israel and JAMESBURG, N.J.--(BUSINESS WIRE)--July 20, 2000 Compugen Ltd., (www.cgen.com) announced today that it has filed a registration statement with the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. Securities and Exchange Commission for the initial public offering of 5,000,000 of its ordinary shares at a proposed public offering price of $10-12 per share. FleetBoston Robertson Stephens Inc. will act as lead underwriter Lead underwriter The head of a syndicate of financial firms that are sponsoring an initial public offering of securities or a secondary offering of securities. Could also apply to bond issues. of the offering with U.S. Bancorp Piper Jaffray and Invemed Associates acting as co-managers. Compugen has also granted the underwriters a 30-day option to purchase up to an additional 750,000 of its ordinary shares to cover any over-allotments. Compugen is a pioneer in the fields of computational genomics and is developing new approaches to computational proteomics. The Company combines the disciplines of advanced mathematics and computer science with molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller to improve the understanding of genomics and proteomics. Compugen has used its expertise in these areas to develop technologies and software applications that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery, therapeutics and diagnostics. Compugen provides innovative products and services to pharmaceutical, biotechnology and other life science organizations, such as Pfrizer, Human Genome Sciences Human Genome Sciences NASDAQ: HGSI is a biopharmaceutical corporation founded in 1992. Its stated purpose is to "discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs. and the U.S. Patent and Trademark Office, through its corporate solutions. In addition, the Company provides these products and services to individual life scientists through its LabOnWeb.com Web site. Compugen is also commercializing the genes and proteins that it discovers through its Novel Genomics division. A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any State in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such State. When available, copies of the preliminary prospectus Preliminary Prospectus A first draft registration statement filed by a firm prior to proceeding with an initial public offering of securities. The document, filed with the Securities & Exchange Commission, is intended to provide pertinent information to prospective shareholders relating to the offering may be obtained from FleetBoston Robertson Stephens Inc., 555 California Street, Suite 2600, San Francisco, CA 94104, 415/781-9700; U.S. Bancorp Piper Jaffray at Piper Jaffray Tower, 222 South Ninth Street, Minneapolis, Minnesota 55402, 612/342-6000; or Invemed Associates LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , 375 Park Avenue, Suite 2205, New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , NY 10152-0189, 212/421-2500. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion